journal article·2024-06-03Open access

Brain–computer interfaces for neuropsychiatric disorders

Lucine L. Oganesian, Maryam M. Shanechi

Nature Reviews Bioengineering· Volume 2· Issue 8

Abstract

Neuropsychiatric disorders such as major depression are a leading cause of disability worldwide with standard treatments, including psychotherapy or medication, failing many patients. Deep brain stimulation holds great potential as an alternative therapy for treatment-resistant cases; however, improving the efficacy of stimulation therapy for neuropsychiatric disorders is hindered by the complexity as well as inter- and/or intra-individual variability in symptom manifestations, neural representations and response to therapy. These challenges motivate the development of brain-computer interfaces (BCIs) that can decode a patient's symptom-state from brain activity as feedback to personalize the stimulation therapy in closed loop. Here, we review progress on developing BCIs for neuropsychiatric care, focusing on neural biomarkers for decoding symptom-states, stimulation site selection and closed-loop stimulation strategies. Moreover, we highlight promising data-driven machine learning and system design approaches and provide a roadmap for realizing these BCIs. Finally, we review current limitations, discuss extensions to other treatment modalities, and outline the required scientific and technological advances. These advances can enable next-generation BCIs that provide an alternative therapy for treatment-resistant neuropsychiatric disorders.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Neurological disorders and treatments · EEG and Brain-Computer Interfaces · Functional Brain Connectivity Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Ferrari, A. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry 9, 137–150 (2022).10.1016/S2215-0366(21)00395-3 ↗
2. Whiteford, H. A. et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382, 1575–1586 (2013).10.1016/S0140-6736(13)61611-6 ↗
3. Rush, A. J. et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry 163, 1905–1917 (2006).10.1176/ajp.2006.163.11.1905 ↗
4. Mrazek, D. A., Hornberger, J. C., Altar, C. A. & Degtiar, I. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013. Psychiatr. Serv. 65, 977–987 (2014).10.1176/appi.ps.201300059 ↗
5. Olchanski, N. et al. The economic burden of treatment-resistant depression. Clin. Ther. 35, 512–522 (2013).10.1016/j.clinthera.2012.09.001 ↗
6. Greenberg, P. E., Fournier, A. A., Sisitsky, T., Pike, C. T. & Kessler, R. C. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatry 76, 155–162 (2015).10.4088/JCP.14m09298 ↗
7. Nuttin, B., Cosyns, P., Demeulemeester, H., Gybels, J. & Meyerson, B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive–compulsive disorder. Lancet 354, 1526 (1999).10.1016/S0140-6736(99)02376-4 ↗
8. Fontaine, D. et al. Effect of subthalamic nucleus stimulation on obsessive–compulsive disorder in a patient with Parkinson disease: case report. J. Neurosurg. 100, 1084–1086 (2004).10.3171/jns.2004.100.6.1084 ↗
9. Mayberg, H. S. et al. Deep brain stimulation for treatment-resistant depression. Neuron 45, 651–660 (2005).10.1016/j.neuron.2005.02.014 ↗
10. Greenberg, B. D. et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology 31, 2384–2393 (2006).10.1038/sj.npp.1301165 ↗
11. Schlaepfer, T. E. et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33, 368–377 (2007).10.1038/sj.npp.1301408 ↗
12. Lozano, A. M. et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 64, 461–467 (2008).10.1016/j.biopsych.2008.05.034 ↗
13. Mallet, L. et al. Subthalamic nucleus stimulation in severe obsessive–compulsive disorder. N. Engl. J. Med. 359, 2121–2134 (2008).10.1056/NEJMoa0708514 ↗
14. Malone, D. A. et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry 65, 267–275 (2009).10.1016/j.biopsych.2008.08.029 ↗
15. Denys, D. et al. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive–compulsive disorder. Arch. Gen. Psychiatry 67, 1061–1068 (2010).10.1001/archgenpsychiatry.2010.122 ↗
16. Sartorius, A. et al. Remission of major depression under deep brain stimulation of the lateral habenula in a therapy-refractory patient. Biol. Psychiatry 67, e9–e11 (2010).10.1016/j.biopsych.2009.08.027 ↗
17. Schlaepfer, T. E., Bewernick, B. H., Kayser, S., Mädler, B. & Coenen, V. A. Rapid effects of deep brain stimulation for treatment-resistant major depression. Biol. Psychiatry 73, 1204–1212 (2013).10.1016/j.biopsych.2013.01.034 ↗
18. Luyten, L., Hendrickx, S., Raymaekers, S., Gabriëls, L. & Nuttin, B. Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive–compulsive disorder. Mol. Psychiatry 21, 1272–1280 (2016).10.1038/mp.2015.124 ↗
19. Riva-Posse, P. et al. A connectomic approach for subcallosal cingulate deep brain stimulation surgery: prospective targeting in treatment-resistant depression. Mol. Psychiatry 23, 843–849 (2017).10.1038/mp.2017.59 ↗
20. Fenoy, A. J. et al. A longitudinal study on deep brain stimulation of the medial forebrain bundle for treatment-resistant depression. Transl. Psychiatry 8, 111 (2018).10.1038/s41398-018-0160-4 ↗
21. Rao, V. R. et al. Direct electrical stimulation of lateral orbitofrontal cortex acutely improves mood in individuals with symptoms of depression. Curr. Biol. 28, 3893–3902.e4 (2018).10.1016/j.cub.2018.10.026 ↗
22. Crowell, A. L. et al. Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression. Am. J. Psychiatry 176, 949–956 (2019).10.1176/appi.ajp.2019.18121427 ↗
23. Denys, D. et al. Efficacy of deep brain stimulation of the ventral anterior limb of the internal capsule for refractory obsessive–compulsive disorder: a clinical cohort of 70 patients. Am. J. Psychiatry 177, 265–271 (2020).10.1176/appi.ajp.2019.19060656 ↗
24. Graat, I. et al. Long-term outcome of deep brain stimulation of the ventral part of the anterior limb of the internal capsule in a cohort of 50 patients with treatment-refractory obsessive–compulsive disorder. Biol. Psychiatry 90, 714–720 (2021).10.1016/j.biopsych.2020.08.018 ↗
25. Menchón, J. M. et al. A prospective international multi-center study on safety and efficacy of deep brain stimulation for resistant obsessive–compulsive disorder. Mol. Psychiatry 26, 1234–1247 (2021).10.1038/s41380-019-0562-6 ↗
26. Scangos, K. W. et al. Closed-loop neuromodulation in an individual with treatment-resistant depression. Nat. Med. 27, 1696–1700 (2021).10.1038/s41591-021-01480-w ↗
27. Shivacharan, R. S. et al. Pilot study of responsive nucleus accumbens deep brain stimulation for loss-of-control eating. Nat. Med. 28, 1791–1796 (2022).10.1038/s41591-022-01941-w ↗
28. Gill, J. L. et al. A pilot study of closed-loop neuromodulation for treatment-resistant post-traumatic stress disorder. Nat. Commun. 14, 2997 (2023).10.1038/s41467-023-38712-1 ↗
29. Dougherty, D. D. et al. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biol. Psychiatry 78, 240–248 (2015).10.1016/j.biopsych.2014.11.023 ↗
30. Holtzheimer, P. E. et al. Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial. Lancet Psychiatry 4, 839–849 (2017).10.1016/S2215-0366(17)30371-1 ↗
31. Widge, A. S. et al. Treating refractory mental illness with closed-loop brain stimulation: progress towards a patient-specific transdiagnostic approach. Exp. Neurol. 287, 461–472 (2017).10.1016/j.expneurol.2016.07.021 ↗
32. Provenza, N. R. et al. The case for adaptive neuromodulation to treat severe intractable mental disorders. Front. Neurosci. 13, 152 (2019).10.3389/fnins.2019.00152 ↗
33. Figee, M. et al. Deep brain stimulation for depression. Neurotherapeutics 19, 1229–1245 (2022).10.1007/s13311-022-01270-3 ↗
34. Drevets, W. C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11, 240–249 (2001).10.1016/S0959-4388(00)00203-8 ↗
35. Williams, L. M. Defining biotypes for depression and anxiety based on large-scale circuit dysfunction: a theoretical review of the evidence and future directions for clinical translation. Depress. Anxiety 34, 9–24 (2017).10.1002/da.22556 ↗
36. Baldermann, J. C. et al. Connectomic deep brain stimulation for obsessive–compulsive disorder. Biol. Psychiatry 90, 678–688 (2021).10.1016/j.biopsych.2021.07.010 ↗
37. Li, N. et al. A unified connectomic target for deep brain stimulation in obsessive–compulsive disorder. Nat. Commun. 11, 3364 (2020).10.1038/s41467-020-16734-3 ↗
38. Riva-Posse, P. et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol. Psychiatry 76, 963–969 (2014).10.1016/j.biopsych.2014.03.029 ↗
39. Mulders, P. C., van Eijndhoven, P. F., Schene, A. H., Beckmann, C. F. & Tendolkar, I. Resting-state functional connectivity in major depressive disorder: a review. Neurosci. Biobehav. Rev. 56, 330–344 (2015).10.1016/j.neubiorev.2015.07.014 ↗
40. Makris, N. et al. Variability and anatomical specificity of the orbitofrontothalamic fibers of passage in the ventral capsule/ventral striatum (VC/VS): precision care for patient-specific tractography-guided targeting of deep brain stimulation (DBS) in obsessive compulsive disorder (OCD). Brain Imaging Behav. 10, 1054–1067 (2016).10.1007/s11682-015-9462-9 ↗
41. Drysdale, A. T. et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat. Med. 23, 28–38 (2017).10.1038/nm.4246 ↗
42. Dunlop, B. W. et al. Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive–behavioral therapy or antidepressant medication for major depressive disorder. Am. J. Psychiatry 174, 533–545 (2017).10.1176/appi.ajp.2016.16050518 ↗
43. Sani, O. G. et al. Mood variations decoded from multi-site intracranial human brain activity. Nat. Biotechnol. 36, 954–961 (2018).10.1038/nbt.4200 ↗
44. Shanechi, M. M. Brain–machine interfaces from motor to mood. Nat. Neurosci. 22, 1554–1564 (2019).10.1038/s41593-019-0488-y ↗
45. Gray, J. P., Müller, V. I., Eickhoff, S. B. & Fox, P. T. Multimodal abnormalities of brain structure and function in major depressive disorder: a meta-analysis of neuroimaging studies. Am. J. Psychiatry 177, 422–434 (2020).10.1176/appi.ajp.2019.19050560 ↗
46. Bijanki, K. R. et al. Defining functional brain networks underlying obsessive–compulsive disorder (OCD) using treatment-induced neuroimaging changes: a systematic review of the literature. J. Neurol. Neurosurg. Psychiatry 92, 776–786 (2021).10.1136/jnnp-2020-324478 ↗
47. Kohoutová, L. et al. Individual variability in brain representations of pain. Nat. Neurosci. 25, 749–759 (2022).10.1038/s41593-022-01081-x ↗
48. Xiao, J. et al. Decoding depression severity from intracranial neural activity. Biol. Psychiatry 94, 445–453 (2023).10.1016/j.biopsych.2023.01.020 ↗
49. Scangos, K. W., State, M. W., Miller, A. H., Baker, J. T. & Williams, L. M. New and emerging approaches to treat psychiatric disorders. Nat. Med. 29, 317–333 (2023).10.1038/s41591-022-02197-0 ↗
50. Sheth, S. A. et al. Deep brain stimulation for depression informed by intracranial recordings. Biol. Psychiatry 92, 246–251 (2022).10.1016/j.biopsych.2021.11.007 ↗
51. Kirkby, L. A. et al. An amygdala–hippocampus subnetwork that encodes variation in human mood. Cell 175, 1688–1700.e14 (2018).10.1016/j.cell.2018.10.005 ↗
52. Basu, I. et al. Closed-loop enhancement and neural decoding of cognitive control in humans. Nat. Biomed. Eng. 7, 576–588 (2023).10.1038/s41551-021-00804-y ↗
53. Sendi, M. S. E. et al. Intraoperative neural signals predict rapid antidepressant effects of deep brain stimulation. Transl. Psychiatry 11, 551 (2021).10.1038/s41398-021-01669-0 ↗
54. Shirvalkar, P. et al. First-in-human prediction of chronic pain state using intracranial neural biomarkers. Nat. Neurosci. 26, 1090–1099 (2023).10.1038/s41593-023-01338-z ↗
55. Nho, Y.-H. et al. Responsive deep brain stimulation guided by ventral striatal electrophysiology of obsession durably ameliorates compulsion. Neuron 112, 73–83.e4 (2024).10.1016/j.neuron.2023.09.034 ↗
56. Kupfer, D. J., Frank, E. & Phillips, M. L. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 379, 1045–1055 (2012).10.1016/S0140-6736(11)60602-8 ↗
57. Boccard, S. G. J., Pereira, E. A. C. & Aziz, T. Z. Deep brain stimulation for chronic pain. J. Clin. Neurosci. 22, 1537–1543 (2015).10.1016/j.jocn.2015.04.005 ↗
58. Shirvalkar, P., Veuthey, T. L., Dawes, H. E. & Chang, E. F. Closed-loop deep brain stimulation for refractory chronic pain. Front. Comput. Neurosci. 12, 18 (2018).10.3389/fncom.2018.00018 ↗
59. Lipsman, N. et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow-up of an open-label trial. Lancet Psychiatry 4, 285–294 (2017).10.1016/S2215-0366(17)30076-7 ↗
60. Vloo, P. D. et al. Long-term follow-up of deep brain stimulation for anorexia nervosa. J. Neurol. Neurosurg. Psychiatry 92, 1135–1136 (2021).10.1136/jnnp-2020-325711 ↗
61. Bina, R. W. & Langevin, J. P. Closed loop deep brain stimulation for PTSD, addiction, and disorders of affective facial interpretation: review and discussion of potential biomarkers and stimulation paradigms. Front. Neurosci. 12, 300 (2018).10.3389/fnins.2018.00300 ↗
62. Langevin, J.-P. et al. Deep brain stimulation of the basolateral amygdala for treatment-refractory posttraumatic stress disorder. Biol. Psychiatry 79, e82–e84 (2016).10.1016/j.biopsych.2015.09.003 ↗
63. de Hemptinne, C. et al. Prefrontal physiomarkers of anxiety and depression in Parkinson’s disease. Front. Neurosci. 15, 1337 (2021).10.3389/fnins.2021.748165 ↗
64. Fridgeirsson, E. A. et al. Patient specific intracranial neural signatures of obsessions and compulsions in the ventral striatum. J. Neural Eng. https://doi.org/10.1088/1741-2552/acbee1 (2023).10.1088/1741-2552/acbee1 ↗
65. Montgomery, S. A. & Asberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry J. Ment. Sci. 134, 382–389 (1979).10.1192/bjp.134.4.382 ↗
66. Widge, A. S. et al. Patient-specific connectomic models correlate with, but do not reliably predict, outcomes in deep brain stimulation for obsessive–compulsive disorder. Neuropsychopharmacology 47, 965–972 (2022).10.1038/s41386-021-01199-9 ↗
67. Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6, 278–296 (1967).10.1111/j.2044-8260.1967.tb00530.x ↗
68. Nahum, M. et al. Immediate Mood Scaler: tracking symptoms of depression and anxiety using a novel mobile mood scale. JMIR MHealth UHealth 5, e44 (2017).10.2196/mhealth.6544 ↗
69. Goodman, W. K. et al. The Yale–Brown Obsessive Compulsive Scale: I. development, use, and reliability. Arch. Gen. Psychiatry 46, 1006–1011 (1989).10.1001/archpsyc.1989.01810110048007 ↗
70. Provenza, N. R. et al. Long-term ecological assessment of intracranial electrophysiology synchronized to behavioral markers in obsessive–compulsive disorder. Nat. Med. 27, 2154–2164 (2021).10.1038/s41591-021-01550-z ↗
71. Gadot, R. et al. Tractography-based modeling explains treatment outcomes in patients undergoing deep brain stimulation for obsessive–compulsive disorder. Biol. Psychiatry https://doi.org/10.1016/j.biopsych.2023.01.017 (2023).10.1016/j.biopsych.2023.01.017 ↗
72. Haeffel, G. J. & Howard, G. S. Self-report: psychology’s four-letter word. Am. J. Psychol. 123, 181–188 (2010).10.5406/amerjpsyc.123.2.0181 ↗
73. Dang, J., King, K. M. & Inzlicht, M. Why are self-report and behavioral measures weakly correlated? Trends Cogn. Sci. 24, 267–269 (2020).10.1016/j.tics.2020.01.007 ↗
74. Gibbons, R. D. et al. Development of a computerized adaptive test for depression. Arch. Gen. Psychiatry 69, 1104–1112 (2012).10.1001/archgenpsychiatry.2012.14 ↗
75. Sani, S., Busnello, J., Kochanski, R., Cohen, Y. & Gibbons, R. D. High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation. Transl. Psychiatry 7, e1207 (2017).10.1038/tp.2017.145 ↗
76. Ekman, P. & Friesen, W. V. Facial Action Coding System (Consulting Psychologists Press, 1977).10.1037/t27734-000 ↗
77. Tao, J. & Tan, T. in Affective Computing and Intelligent Interaction (eds Tao, J., Tan, T. & Picard, R. W.) 981–995 (Springer, 2005).10.1007/11573548_125 ↗
78. Weninger, F., Wöllmer, M. & Schuller, B. in Emotion Recognition (eds Konar, A. & Chakraborty, A.) 237–267 (John Wiley & Sons, 2015).10.1002/9781118910566.ch10 ↗
79. Sullivan, C. R. P., Olsen, S. & Widge, A. S. Deep brain stimulation for psychiatric disorders: from focal brain targets to cognitive networks. NeuroImage 225, 117515 (2021).10.1016/j.neuroimage.2020.117515 ↗
80. McTeague, L. M. et al. Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. Am. J. Psychiatry 174, 676–685 (2017).10.1176/appi.ajp.2017.16040400 ↗
81. Yousefi, A. et al. Decoding hidden cognitive states from behavior and physiology using a Bayesian approach. Neural Comput. 31, 1751–1788 (2019).10.1162/neco_a_01196 ↗
82. Cuthbert, B. N. & Insel, T. R. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 11, 126 (2013).10.1186/1741-7015-11-126 ↗
83. Etkin, A. & Wager, T. D. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am. J. Psychiatry 164, 1476–1488 (2007).10.1176/appi.ajp.2007.07030504 ↗
84. Haber, S. N. et al. Circuits, networks, and neuropsychiatric disease: transitioning from anatomy to imaging. Biol. Psychiatry 87, 318–327 (2020).10.1016/j.biopsych.2019.10.024 ↗
85. Siddiqi, S. H. et al. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease. Nat. Hum. Behav. 5, 1707–1716 (2021).10.1038/s41562-021-01161-1 ↗
86. Mayberg, H. S. et al. Reciprocal limbic–cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry 156, 675–682 (1999).10.1176/ajp.156.5.675 ↗
87. Scangos, K. W., Makhoul, G. S., Sugrue, L. P., Chang, E. F. & Krystal, A. D. State-dependent responses to intracranial brain stimulation in a patient with depression. Nat. Med. 27, 229–231 (2021).10.1038/s41591-020-01175-8 ↗
88. Ahmari, S. E. & Dougherty, D. D. Dissecting OCD circuits: from animal models to targeted treatments. Depress. Anxiety 32, 550–562 (2015).10.1002/da.22367 ↗
89. Fettes, P., Schulze, L. & Downar, J. Cortico–striatal–thalamic loop circuits of the orbitofrontal cortex: promising therapeutic targets in psychiatric illness. Front. Syst. Neurosci. 11, 25 (2017).10.3389/fnsys.2017.00025 ↗
90. Choi, K. S., Riva-Posse, P., Gross, R. E. & Mayberg, H. S. Mapping the ‘depression switch’ during intraoperative testing of subcallosal cingulate deep brain stimulation. JAMA Neurol. 72, 1252–1260 (2015).10.1001/jamaneurol.2015.2564 ↗
91. Starr, P. A. Totally implantable bidirectional neural prostheses: a flexible platform for innovation in neuromodulation. Front. Neurosci. 12, 619 (2018).10.3389/fnins.2018.00619 ↗
92. Goyal, A. et al. The development of an implantable deep brain stimulation device with simultaneous chronic electrophysiological recording and stimulation in humans. Biosens. Bioelectron. 176, 112888 (2021).10.1016/j.bios.2020.112888 ↗
93. Allawala, A. et al. A novel framework for network-targeted neuropsychiatric deep brain stimulation. Neurosurgery 89, E116–E120 (2021).10.1093/neuros/nyab112 ↗
94. Scangos, K. W. et al. Pilot study of an intracranial electroencephalography biomarker of depressive symptoms in epilepsy. J. Neuropsychiatry Clin. Neurosci. 32, 185–190 (2020).10.1176/appi.neuropsych.19030081 ↗
95. Herrington, T. M., Cheng, J. J. & Eskandar, E. N. Mechanisms of deep brain stimulation. J. Neurophysiol. 115, 19–38 (2016).10.1152/jn.00281.2015 ↗
96. Ashkan, K., Rogers, P., Bergman, H. & Ughratdar, I. Insights into the mechanisms of deep brain stimulation. Nat. Rev. Neurol. 13, 548–554 (2017).10.1038/nrneurol.2017.105 ↗
97. van Hartevelt, T. J. et al. Neural plasticity in human brain connectivity: the effects of long term deep brain stimulation of the subthalamic nucleus in Parkinson’s disease. PLoS ONE 9, e86496 (2014).10.1371/journal.pone.0086496 ↗
98. Merola, A. et al. New frontiers for deep brain stimulation: directionality, sensing technologies, remote programming, robotic stereotactic assistance, asleep procedures, and connectomics. Front. Neurol. 12, 1149 (2021).10.3389/fneur.2021.694747 ↗
99. Gilron, R. et al. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson’s disease. Nat. Biotechnol. 39, 1078–1085 (2021).10.1038/s41587-021-00897-5 ↗
100. Larkin, H. D. Apple Watch Parkinson disease symptom monitor is cleared. JAMA 328, 416 (2022).